Evidence map›Paper›PMID 33846805›Full record

ArticleOncology reports2021

PRIMA‑1

Xiao-Lan Li, Jianbiao Zhou, Chen-Jing Xia, Han Min, Zhong-Kai Lu, Zhi-Rong Chen

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Xiao-Lan Li *Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Jianbiao Zhou *Cancer Science Institute of Singapore, National University of Singapore, Centre for Translational Medicine, Singapore 117599, Republic of Singapore.
Chen-Jing XiaDepartment of Gastroenterology, Traditional Chinese Medicine Hospital of Kunshan, Suzhou, Jiangsu 215300, P.R. China.
Han MinDepartment of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Zhong-Kai LuDepartment of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Zhi-Rong ChenDepartment of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Nanjing Medical University · CNNational University Cancer Institute, Singapore · SGSuzhou Municipal Hospital · CNTraditional Chinese Medicine Hospital of Kunshan · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p53‑reactivation and induction of massive apoptosis‑1, APR‑017 methylated (PRIMA‑1

Indexed as

AMP-Activated Protein KinasesApoptosisAutophagyAutophagy-Related Protein-1 HomologCell Line, TumorCell ProliferationClass III Phosphatidylinositol 3-KinasesColorectal NeoplasmsHumansIntracellular Signaling Peptides and ProteinsMutationQuinuclidinesSignal TransductionTOR Serine-Threonine KinasesTumor Suppressor Protein p53Up-RegulationAMP-Activated Protein KinasesAutophagy-Related Protein-1 HomologClass III Phosphatidylinositol 3-KinaseseprenetapoptIntracellular Signaling Peptides and ProteinsMTOR protein, humanQuinuclidinesTOR Serine-Threonine KinasesTP53 protein, humanTumor Suppressor Protein p53ULK1 protein, humanautophagycolorectal canceroncotherapyp53p53‑reactivation and induction of massive apoptosis‑1methylated

Identifiers

PMID33846805
PMCPMC8025076
OpenAlexW3149021142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.